Sublingual desensitization: A new approach to latex allergy problem

Anesthesia and Analgesia

Volumn 95, Issue 4, 2002, Pages 956-960

  Patriarca, Giampiero ^a   Nucera, Eleonora ^a   Pollastrini, Emanuela ^a   Roncallo, Chiara ^a   Buonomo, Alessandro ^a   Bartolozzi, Francesco ^a   De Pasquale, Tiziana ^a   Gasbarrini, Giovanni ^a   Schiavino, Domenico ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC AGENT; LATEX EXTRACT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGY; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT URTICARIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESENSITIZATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SCHOOL CHILD; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036784806     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200210000-00031     Document Type: Article

References (16)

1. Poley GE Jr, Slater JE. Latex allergy. J Allergy Clin Immunol 2000;105:1054-62.
2. Lauvaud F, Prevost A, Cossart C, et al. Allergy to latex, avocado, pear and banana: evidence for a 30KD antigen in immunoblotting. J Allergy Clin Immunol 1995;95:557-64.
3. Lauvaud F, Cossart C, Reiter V, et al. Latex allergy in a patient with allergy to fruit. Lancet 1992;339:492-3.
4. Breiteneder H. The allergens of Hevea brasiliensis. ACI Int 1998; 10:101-8.
5. Pereira C, Rico P, Lourenço M, et al. Specific immunotherapy for occupational latex allergy. Allergy 1999;54:291-3.
6. Leynadier F, Herman D, Vervloet D, Andre C. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 2000;106: 585-90.
7. Nucera E, Schiavino D, Buonomo A, et al. Latex rush desensitization. Allergy 2001;56:86-7.
8. Patriarca G, Nucera E, Buonomo A, et al. Latex allergy desensitization by exposure protocol: five case reports. Anesth Analg 2002;94:754-8.
9. Nucera E, Schiavino D, Pollastrini E, et al. Desensitization to latex by percutaneous route. J Investig Allergol Immunol. 2002; 12:134-5.
10. Fuchs T, Spitzauer S, Vente C, et al. Natural latex, grass pollen, and weed pollen share IgE epitopes. J Allergy Clin Immunol 1997;100:356-64.
11. Marks JG, Belsito DV, De Leo VA, et al. North American Contact Dermatitis Group patch results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998; 38:911-8.
12. Czuppon AB, Allmers H, Baur X. Evaluation of diagnostic procedures in type I latex allergy. ACI Int 2000;12:98-104.
13. Kurtz KM, Hamilton RG, Adkinson NF Jr. Role and application of provocation in the diagnosis of occupational latex allergy. Ann Allergy Asthma Immunol 1999;83:634-9.
14. Pradalier A, Basset D, Claudel A, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-28.
15. Bousquet J, Scheinmann P, Guinnepain MT, et al. Sublingualswallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249-60.
16. Perkin JE. The latex and food allergy connection. J Am Diet Assoc 2000;100:1381-4.